Aethera Biotech Forges Strategic Collaboration with China's Shang Renée Skincare to Introduce CROP (Controlled Release of Optimized Plants) Patent Technology into Chinese Market

ROME, June 06, 2025--(BUSINESS WIRE)--Aethera Biotech officially announced a strategic partnership with Chinese premium skincare brand Shang Renée, marking the latter as Aethera Biotech's first collaborative partner in the Chinese market. This collaboration not only introduces the internationally pioneering CROP patent technology to China but has also led to the joint establishment of the CELL Laboratory in Italy, laying a robust foundation for scientific innovation in skincare.
CROP technology is an exclusive global patent held by Aethera Biotech. This innovation utilizes 100% natural laboratory cultivation to develop plant callus tissue cells (phytocomplexes), fully preserving the highly active components and regenerative properties of plants. The CELL Laboratory will focus on cellular research of core ingredients such as EchinAge CROP-G and other rare botanical specimens for Shang Renée, providing robust scientific support for the brand's skincare formulations.
The EchinAge CROP-G compound, cultivated through this proprietary technology, exhibits elevated concentrations of modularized polyphenols and polysaccharides. Compared to conventional Echinacea extracts, EchinAge CROP-G demonstrates significantly enhanced polyphenolic content. Its dermatological efficacy manifests through three primary mechanisms:
Rapid oxidative stress reduction via ROS suppression;
Dual-targeted anti-inflammatory action through inhibition of iNOS and COX2 expression;
Skin firming via attenuation of fibroblast-protective activity.
Clinically validated outcomes include measurable improvements in skin texture refinement and reduction of contour wrinkles, supported by comprehensive experimental data.
Centered on the philosophy of "Natural Regeneration," Shang Renée is committed to delivering transformative solutions for skin repair, firming, and wrinkle reduction. This partnership will leverage Aethera Biotech's expertise in plant cell cultivation, synergizing with active compounds like EchinAge CROP-G to develop groundbreaking skincare innovations.
The CEO of Aethera Biotech stated: "We are thrilled to deepen our collaboration with Shang Renée. Through joint research at the CELL Laboratory, we aim to translate avant-garde plant cell technologies into tangible skincare advancements, offering Chinese consumers purer and more efficacious skincare experiences."
View source version on businesswire.com: https://www.businesswire.com/news/home/20250529227206/en/
Contacts
Claire Chanservice@shangrenee.com

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

CNBC

3 hours ago

• CNBC

U.S. calls on China to prevent Iran from closing Strait of Hormuz and disrupting global oil flows

U.S. Secretary of State Marco Rubio on Sunday called for China to prevent Iran from closing the Strait of Hormuz, one of the most important trade routes for crude oil in the world. "I encourage the Chinese government in Beijing to call them about that, because they heavily depend on the Straits of Hormuz for their oil," Rubio said in an interview on Fox News. China is Iran's most important oil customer and maintains friendly relations with the Islamic Republic. Iran's foreign minister warned earlier Sunday that the Islamic Republic "reserves all options to defend its sovereignty," after the U.S. bombed three key nuclear sites over the weekend. Iranian state-owned media, meanwhile, reported that Iran's parliament backed closing the Strait of Hormuz, citing a senior lawmaker. However, the final decision to close the strait lies with Iran's national security council, according to the report. An attempt to block the narrow waterway between Iran and Oman could have profound consequences for the global economy. Some 20 million barrels per day of crude oil, or 20% of global consumption, flowed through the strait in 2024, according to the Energy Information Administration. Oil prices could shoot above $100 per barrel if the strait is closed for a prolonged period, according to Goldman Sachs and consulting firm Rapidan Energy. Iran is the third-largest oil producer in OPEC, pumping 3.3 million barrels per day. The Islamic Republic exports at least 1.6 million bpd, with nearly 80% sold to China, according to the EIA. Rubio said it would be "economic suicide" for Iran to close the strait. "We retain options to deal with that," the U.S. secretary of state said. "It would hurt other countries' economies a lot worse than ours," Rubio said. "It would be, I think, a massive escalation that would merit a response, not just by us, but from others." The U.S. Fifth Fleet is stationed in Bahrain and tasked with protecting maritime trade in the Persian Gulf. Oil market participants generally believe the U.S. Navy would swiftly vanquish any attempt by Iran to block the Strait of Hormuz. But some analysts warn that the market is underestimating the risk. "They could disrupt, in our view, shipping through Hormuz by a lot longer than the market thinks," said Bob McNally, founder of Rapidan Energy and former energy advisor to President George W. Bush. Shipping could be interrupted for weeks or months, McNally said, rather than the oil market's view that the U.S. Navy would resolve the situation in hours or days. "It would not be a cakewalk," McNally told CNBC.

Business Upturn

5 hours ago

• Business Upturn

NSSC DEADLINE TUESDAY: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages NAPCO Security Technologies, Inc. Investors to Secure Counsel Before Important June 24 Deadline in Securities Class Action

NEW YORK, June 22, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of NAPCO Security Technologies, Inc. (NASDAQ: NSSC) between February 5, 2024 and February 3, 2025, both dates inclusive (the 'Class Period'), of the important June 24, 2025 lead plaintiff deadline. SO WHAT: If you purchased NAPCO securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the NAPCO class action, go to or call Phillip Kim, Esq. at 866-767-3653 or email [email protected] for more information. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 24, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made false and misleading statements. Specifically, they created the false impression that they possessed reliable information pertaining to NAPCO's projected revenue outlook and anticipated growth while also minimizing risk from seasonality and macroeconomic fluctuations. In truth, NAPCO's optimistic margin growth goals and demand reassurances for NAPCO's hardware sales fell short of reality; NAPCO was simply not equipped to adequately forecast demand for its products or otherwise minimized the impact of potential demand fluctuations to continue to promote its lofty margin projections which relied upon continually increased sales volumes. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the NAPCO class action, go to or call Phillip Kim, Esq. at 866-767-3653 or email [email protected] for more information. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: on Twitter: or on Facebook: Attorney Advertising. Prior results do not guarantee a similar outcome. ——————————- Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected]

Yahoo

5 hours ago

• Yahoo

See how much an investor needs in an ISA to fund an £888 monthly passive income

Passive income has always struck me as the holy grail of investing. A regular payment landing in my account, without me having to lift a finger. Ideally, generated inside a Stocks and Shares ISA. To generate £888 a month, or £10,656 a year, I'd need to think carefully about what kind of payout I'm aiming for. Many people use the so-called 4% rule, which assumes investors draws 4% a year from a pot without running it down too fast. That would mean needing a hefty £266,400 to hit my income target. That's quite a chunk of change. But I think it's possible to bring that number down a fair bit, depending on the stocks I pick and the yields they offer. One of my favourite second income stocks is FTSE 100 wealth manager M&G (LSE: MNG). A year ago, it was yielding close to 10%. That's since dipped to around 7.9% as the shares have enjoyed a strong run. They've climbed 25% over 12 months, and 60% over five years. Not bad for a stock many wrote off as purely an income play. Possibly including me. M&G isn't without risk. Markets remain shaky, and the long shift to passive investing is still a threat to its active management model. With interest rates staying higher for longer, income seekers may find cash and bonds more tempting than equity income stocks, where capital is at risk. The dividend is set for modest growth, with the board targeting 2% annual increases. But there's still potential. On 30 May, M&G revealed that Japan's Dai-ichi Life will be taking a 15% stake, bringing an estimated $6bn of new investment into its funds over the next five years. That has given sentiment a lift. I suspect share price growth may slow after its strong run, but I think M&G is still worth considering with a long-term view. Even so, I wouldn't pile everything into a single income stock, no matter how juicy the yield. Instead, I'd spread my money around and aim for a more realistic average yield of 5.5%. With a 5.5% yield, I'd need around £193,745 in my ISA to generate £10,656 of annual income and hit that £888 monthly goal. That assumes I live off the dividends, and leave the capital untouched to keep growing over time. That's almost £195,000 which sounds like a lot, and it is. But over a 40-year working life, I think it's achievable. For example, investing just £75 a month at an average growth rate of 7% – roughly in line with the long-term FTSE 100 average – could do the trick. Naturally, there are risks. Stock markets can go down as well as up. Inflation will nibble away at the buying power of that £888. So I'd encourage anyone with long-term ambitions to save more if they can. But this shows that with patience, consistency and a little know-how, building a decent ISA income pot is far from impossible. I'd say income investors might consider buying high-yield stocks where the fundamentals still stack up, while diversifying to help smooth out the ride. The post See how much an investor needs in an ISA to fund an £888 monthly passive income appeared first on The Motley Fool UK. More reading 5 Stocks For Trying To Build Wealth After 50 One Top Growth Stock from the Motley Fool Harvey Jones has positions in M&g Plc. The Motley Fool UK has recommended M&g Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Motley Fool UK 2025